Stocks/BRNS

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

BRNS

↓ PDF (Pro)
Barinthus Biotherapeutics plc American Depositary Shares
HealthcareBiotechnologyUnited StatesNASDAQ
$0.70
+10.95%today
MKT CAP
$29M
+22.8% · 1Y
Earnings History
-57.6%
+38.2%
+21.7%
+50.0%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$0.70
Low
$4.00
Analyst Mean
$5.50
High
$7.00
2 analystsNone
Full Financials
Trailing P/E-
Forward P/E-0.6x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership13.1%
Institutional Ownership40.9%
Short % of Float0.03%
Days to Cover0.2d
1 Week-1.6%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
M&G Plcinstitution12.72%$0.00B+0.00%2025-12-31
HSG Holding Ltdinstitution3.48%$0.00B+0.00%2025-12-31
DC Funds, LPinstitution1.57%$0.00B+0.00%2025-12-31
Renaissance Technologies, LLCinstitution0.35%$0.00B+115.84%2025-12-31
Johns Hopkins Universityinstitution0.30%$0.00B+0.00%2025-12-31
Citadel Advisors Llcinstitution0.29%$0.00B+100.00%2025-12-31
Baird Financial Group, Inc.institution0.26%$0.00B-1.40%2025-12-31
Rangeley Capital, LLCinstitution0.21%$0.00B+100.00%2025-12-31
HighTower Advisors, LLCinstitution0.09%$0.00B+0.00%2026-03-31
Rhumbline Advisersinstitution0.03%$0.00B+100.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.03%$0.00B+0.00%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for BRNS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.